The article Health Canada Approves Diamond Therapeutics’ Phase 2 Trial of Low-Dose Psilocybin was originally published on Microdose. “Building...
The article The Microbiome and Psychedelics: It’s Not All in Your Head was originally published on Microdose. The Microbiome and Psychedelics. We are...
Zip reported a record group quarterly revenue of $188m for the half while Kogan's profit dropped by half in the, ... Read More The post ASX...
Zip reported a record group quarterly revenue of $188m for the half while Kogan's profit dropped by half in the, ... Read More The post ASX...
Could synthetic psychedelics help pave the way? The post Operators Seek to Reduce Cost of Psychedelics appeared first on Green Market Report.
Entrepreneurs opening psilocybin businesses in Oregon face difficulties finding liability insurance and sympathetic landlords. The post Regulatory Hurdles...
Filament Health Corp. (OTCQB: FLHLF | NEO: FH | FSE: 7QS), a clinical–stage natural psychedelic drug development company, today announced the approval...
The company has launched a Community Stakeholder Initiative that allows more people to invest in next-generation MDMA-like medicines. The post Tactogen...
The article Microdosing DMT to Treat Strokes: Not as Trippy as it Sounds was originally published on Microdose. On January 17th, the company Algernon...
Investing in psychedelic companies has become increasingly popular in the past few years. Here at Psychedelic Invest, our goal is to connect you to the...